ERBB2 and breast carcinoma: In daily life, the ER/PR/HER2 status is determined multiple times in many breast cancer patients: first on specimen derived from a needle biopsy taken for initial diagnosis, and second on the whole tumor specimen obtained by tumor resection [4].